Reduced-frequency GLP-1 as a maintenance strategy: in this case series, patients who tapered from weekly semaglutide/tirzepatide to less frequent dosing maintained weight loss, body composition, and metabolic syndrome gains, supporting structured de-escalation to lower burden without sacrificing efficacy
This product is GMO, gluten and allergen free
Kidney & Liver Love: Emerging evidence suggests potential benefits for kidney health and the reduction of fatty liver disease, opening up exciting new avenues of research
In recent years, stronger versions of these GLP-1s were approved to help people with overweight and obesity
Iron (if deficient): To support oxygen transport
The most common side effects are gastrointestinal, including diarrhoea, abdominal cramping, nausea, and bloating